Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The most notable recent filing activity centres on NVDA. Independent director Mark Stevens disclosed sales totalling over $410 million across filings dated 2 September. He sold roughly 1.85 million shares between 31 August and 2 September at prices around $220. General Counsel Tim Teter also filed sales of approximately $6.5 million on the same dates. Both sets of trades are vendor-reported and the EDGAR first-party tables were unavailable in this environment, so 10b5-1 plan status cannot be confirmed. Treat the director sales as a weaker signal if pre-planned.
At TWLO, a more striking pattern emerged. A hedge fund board representative, Andrew Stafman, filed a $123.5 million block sale on 12 August, offloading 500,000 shares. That is a large discretionary-looking exit by a board-level holder. CFO Aidan Viggiano filed smaller sales around $285,000 in mid-August, adding to the selling tone.
At EVO, an associate-level insider at Evolution AB sold roughly $7 million worth of shares across several tranches in late August, filed 27 August.
The activist 13D table was not accessible via the available SQL environment, so fresh Schedule 13D filings could not be screened. That is the key data gap in this note.
The pattern across names skews heavily toward selling, with no significant open-market purchases above $1 million identified in the dataset window.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
